Am J Kidney Dis
- HONDA D, Okunaga I, Omote D, Inoue H, et al
Anti-Neuron-Derived Neurotrophic Factor Antibodies in Secondary Membranous
Nephropathy Caused by Syphilis: A Case Report.
Am J Kidney Dis. 2024 Mar 22:S0272-6386(24)00685.
Ann Neurol
- ALPING P, Neovius M, Piehl F, Frisell T, et al
Real-World Healthcare Cost Savings and Reduced Relapse Rate with Off-Label
Rituximab versus Disease-Modifying Treatments Approved for Relapsing-Remitting
Multiple Sclerosis: A Nationwide Cost-Effectiveness Study.
Ann Neurol. 2024 Mar 26. doi: 10.1002/ana.26914.
BMC Neurol
- KURI A, Henshall DE, Chaudhry D, Ooi SZY, et al
Delays in Multiple Sclerosis diagnosis (DIMES): protocol for a multicentre,
observational study of multiple sclerosis diagnostic pathways in the United
Kingdom and Republic of Ireland.
BMC Neurol. 2024;24:105.
Brain
- MAINERO C, Miscioscia A, Treaba CA
Cortical remyelination in multiple sclerosis: a target for disease monitoring and
intervention.
Brain. 2024 Mar 27:awae083. doi: 10.1093.
Diabetes Res Clin Pract
- HATLE H, Skrivarhaug T, Bjorgaas MR, Asvold BO, et al
Prevalence and associations of impaired awareness of hypoglycemia in a pediatric
type 1 diabetes population - The Norwegian Childhood Diabetes Registry.
Diabetes Res Clin Pract. 2024;209:111093.
- KNAUS L, Quarella M, Buser M, Maeder MT, et al
Screening for heart failure in patients with diabetes mellitus in tertiary care -
A SwissDiab study.
Diabetes Res Clin Pract. 2024;209:111565.
- ZARE DEHNAVI A, Elmitwalli I, Alsharif HOH, Shervin Razavi A, et al
Effects of ADHD and ADHD treatment on glycemic management in type 1 diabetes: A
systematic review and meta-analysis of observational studies.
Diabetes Res Clin Pract. 2024;209:111566.
- ADDALA A, Medina Penaranda R, Naranjo D, Maahs DM, et al
Intersectional identities play a role in perceived discrimination for families
living with type 1 diabetes.
Diabetes Res Clin Pract. 2024;209:111568.
- MINSKY N, Arnon Klug L, Kolobov T, Tarshish E, et al
Glycemic outcomes and patient satisfaction and self-management improves in
transition from standard to virtual multidisciplinary care.
Diabetes Res Clin Pract. 2024;209:111587.
- GRASSI BA, Teresa Onetto M, Sanchez C, Tapia N, et al
Effect of low dose Semaglutide in people with Type 1 Diabetes and excess weight.
Diabetes Res Clin Pract. 2024;209:111593.
- LIARAKOS AL, Hasan N, Crabtree TSJ, Leelarathna L, et al
Real-world outcomes of Omnipod DASH system use in people with type 1 diabetes:
Evidence from the Association of British Clinical Diabetologists (ABCD) study.
Diabetes Res Clin Pract. 2024;209:111597.
- LIN YK, Hepworth E, de Zoysa N, McCurley J, et al
Relationships of hypoglycemia awareness, hypoglycemia beliefs, and continuous
glucose monitoring glycemic profiles with anxiety and depression symptoms in
adults with type 1 diabetes using continuous glucose monitoring systems.
Diabetes Res Clin Pract. 2024;209:111596.
- GENTILE S, Strollo F
Should insulin needles be used once or several times? An unresolved conundrum.
Diabetes Res Clin Pract. 2024;209:111600.
- PLACHY L, Neuman V, Velichova K, Slavenko MG, et al
Telemedicine maintains good glucose control in children with type 1 diabetes but
is not time saving for healthcare professionals: KITES randomized study.
Diabetes Res Clin Pract. 2024;209:111602.
J Autoimmun
- REUSCHLE Q, Van Heddegem L, Bosteels V, Moncan M, et al
Loss of function of XBP1 splicing activity of IRE1alpha favors B cell tolerance
breakdown.
J Autoimmun. 2024;142:103152.
- LIBERATORE J, Nguyen Y, Hadjadj J, Cohen P, et al
Risk factors for hypogammaglobulinemia and association with relapse and severe
infections in ANCA-associated vasculitis: A cohort study.
J Autoimmun. 2024;142:103130.
- KELLY S, Jackson KJ, Peters TJ, Suan D, et al
Isolation and characterisation of PR3-specific B cells and their immunoglobulin
sequences.
J Autoimmun. 2024;142:103129.
- REYNOLDS JA, Li Y, Herlitz L, Mohan C, et al
Novel biomarker discovery through comprehensive proteomic analysis of lupus mouse
serum.
J Autoimmun. 2024;142:103134.
- XU C, Zhang T, Wang H, Zhu L, et al
Integrative single-cell analysis reveals distinct adaptive immune signatures in
the cutaneous lesions of pemphigus.
J Autoimmun. 2024;142:103128.
- MERINO-VICO A, van Hamburg JP, Tuijnenburg P, Frazzei G, et al
Targeting NF-kappaB signaling in B cells as a potential new treatment modality for
ANCA-associated vasculitis.
J Autoimmun. 2024;142:103133.
- DZIEDZIC A, Michlewska S, Jozwiak P, Debski J, et al
Quantitative and structural changes of blood platelet cytoskeleton proteins in
multiple sclerosis (MS).
J Autoimmun. 2024;145:103204.
J Nephrol
- HU D, Wang Z, Wang S, Li Y, et al
Lymphatic vessels in patients with crescentic glomerulonephritis: association
with renal pathology and prognosis.
J Nephrol. 2024 Mar 25. doi: 10.1007/s40620-024-01903.
- ROBERT JT, Rajaram A, Fiset PO, Bernard C, et al
Class V lupus nephritis recurrence with histologic resolution in a kidney
transplant recipient on a pregnancy-adapted immunosuppression protocol: a lesson
for the clinical nephrologist.
J Nephrol. 2024 Mar 26. doi: 10.1007/s40620-024-01920.
J Neurol
- GOERECI Y, Ellenberger D, Rommer P, Dunkl V, et al
Persons with multiple sclerosis older than 55 years: an analysis from the German
MS registry.
J Neurol. 2024 Mar 22. doi: 10.1007/s00415-024-12286.
- LAUVSNES MB, Zetterberg H, Blennow K, Kvaloy JT, et al
Correction to: Neurofilament light in plasma is a potential biomarker of central
nervous system involvement in systemic lupus erythematosus.
J Neurol. 2024 Mar 23. doi: 10.1007/s00415-024-12238.
- PILOTTO S, Floris M, Solla P, Pugliatti M, et al
Determinants of self-perceived quality of life in mildly disabled multiple
sclerosis patients: a cross-sectional study.
J Neurol. 2024 Mar 25. doi: 10.1007/s00415-024-12244.
- FUCHS L, Shelly S, Vigiser I, Kolb H, et al
Real-World experience with efgartigimod in patients with myasthenia gravis.
J Neurol. 2024 Mar 25. doi: 10.1007/s00415-024-12293.
- ZHANG H, Ma J, Feng Y, Ma H, et al
Efgartigimod in the treatment of Guillain-Barre syndrome.
J Neurol. 2024 Mar 26. doi: 10.1007/s00415-024-12321.
- MALLUCCI G, Ferraro OE, Trojano M, Amato MP, et al
Early prediction of unfavorable evolution after a first clinical episode
suggestive of multiple sclerosis: the EUMUS score.
J Neurol. 2024 Mar 26. doi: 10.1007/s00415-024-12304.
- SCHALLER-PAULE MA, Maiworm M, Schafer JH, Friedauer L, et al
Matching proposed clinical and MRI criteria of aggressive multiple sclerosis to
serum and cerebrospinal fluid markers of neuroaxonal and glial injury.
J Neurol. 2024 Mar 27. doi: 10.1007/s00415-024-12299.
- GUILLEMIN C, Vandeleene N, Charonitis M, Requier F, et al
Brain microstructure is linked to cognitive fatigue in early multiple sclerosis.
J Neurol. 2024 Mar 28. doi: 10.1007/s00415-024-12316.
- TEDONE N, Vizzino C, Meani A, Gallo A, et al
The brief repeatable battery of neuropsychological tests (BRB-N) version a:
update of Italian normative data from the Italian Neuroimaging Network Initiative
(INNI).
J Neurol. 2024;271:1813-1823.
- WANG Y, Hu C, Aljarallah S, Reyes Mantilla M, et al
Expanding clinical profiles and prognostic markers in stiff person syndrome
spectrum disorders.
J Neurol. 2024;271:1861-1872.
- MCWILLIAM O, Gramkow MH, Blaabjerg M, Clemmensen FK, et al
Differentiating anti-IgLON5 disease and Lewy body dementia: a systematic review.
J Neurol. 2024;271:1707-1716.
Kidney Int
- SELVASKANDAN H, Barratt J
Charting new frontiers in IgA nephropathy: a paradigm shift toward precision
medicine and early intervention?
Kidney Int. 2024;105:659-661.
Mult Scler
- MAILLART E, Redolfi S, Louapre C, Houot M, et al
Clinical correlates of respiratory disorders in patients with severe multiple
sclerosis: A cross-sectional cohort.
Mult Scler. 2024 Mar 22:13524585241238840. doi: 10.1177/13524585241238840.
- SORENSEN PS, Bramow S, Magyari M, Werdelin L, et al
Torben Fog - A Danish pioneer in a multi-faceted spectrum of multiple sclerosis
research.
Mult Scler. 2024 Mar 24:13524585241239506. doi: 10.1177/13524585241239506.
- SIMPSON AC, Hu C, Mowry EM, Naismith RT, et al
Structural MRI measures are associated with fatigue severity and persistence in a
large, real-world cohort of people with multiple sclerosis.
Mult Scler. 2024 Mar 25:13524585241239473. doi: 10.1177/13524585241239473.
Neurol Clin Pract
- SUZUKI S, Uzawa A, Nagane Y, Masuda M, et al
Therapeutic Responses to Efgartigimod for Generalized Myasthenia Gravis in Japan.
Neurol Clin Pract. 2024;14:e200276.
Neurology
- PAPP V, Magyari M, Moller S, Sellebjerg F, et al
Mortality of the Danish Nationwide AQP4 Antibody-Seropositive Neuromyelitis
Optica Spectrum Disorder Patient Cohort.
Neurology. 2024;102:e209147.
- DEMORTIERE S, Joubert B, Benaiteau M, Hilezian F, et al
Anti-IgLON5 Disease With Inaugural Bilateral Neuropapillitis.
Neurology. 2024;102:e209284.
- MOEHLMAN M, Kornbluh AB
Teaching NeuroImage: Anti-NMDA Receptor Encephalitis Presenting With Cerebellitis
in a Pediatric Patient.
Neurology. 2024;102:e209259.
-
Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria: A Longitudinal,
Prospective, Multicenter Study.
Neurology. 2024;102:e209214.
PLoS One
- CARATIS F, Opielka M, Hausmann M, Velasco-Estevez M, et al
The proton-sensing receptors TDAG8 and GPR4 are differentially expressed in human
and mouse oligodendrocytes: Exploring their role in neuroinflammation and
multiple sclerosis.
PLoS One. 2024;19:e0283060.
- LEREIM RR, Nytrova P, Guldbrandsen A, Havrdova EK, et al
Natalizumab promotes anti-inflammatory and repair effects in multiple sclerosis.
PLoS One. 2024;19:e0300914.
- BRNABIC AJM, Curtis SE, Johnston JA, Lo A, et al
Incidence of type 2 diabetes, cardiovascular disease and chronic kidney disease
in patients with multiple sclerosis initiating disease-modifying therapies:
Retrospective cohort study using a frequentist model averaging statistical
framework.
PLoS One. 2024;19:e0300708.
Thyroid
- LIU S, Lu C, He L, Shan Z, et al
Vitamin E intake and prevalence rates of thyroid dysfunction and autoimmune
thyroiditis: A cross-sectional analysis of NHANES data.
Thyroid. 2024 Mar 27. doi: 10.1089/thy.2023.0561.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016